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ABSTRACT
Although the knowledge accumulated on the tran-
scriptional regulations of eukaryotes is significant,
the knowledge on their translational regulations
remains limited. Thus, we performed a comprehen-
sive detection of terminal oligo-pyrimidine (TOP),
which is one of the well-characterized cis-regulatory
motifs for translational controls located immediately
downstream of the transcriptional start sites of
mRNAs. Utilizing our precise 5’-end information of
the full-length cDNAs, we could screen 1645 candi-
date TOP genes by position specific matrix search.
Among them, not only 75 out of 78 ribosomal protein
genes but also eight previously identified non-
ribosomal-protein TOP genes were included. We
further experimentally validated the translational
activities of 83 TOP candidate genes. Clear transla-
tional regulations exerted on the stimulation of
12-O-tetradecanoyl-1-phorbol-13-acetate for at
least 41 of them was observed, indicating that
there should be a few hundreds of human genes
which are subjected to regulation at translation
levels via TOPs. Our result suggests that TOP genes
code not only formerly characterized ribosomal
proteins and translation-related proteins but also a
wider variety of proteins, such as lysosome-related
proteins and metabolism-related proteins, playing
pivotal roles in gene expression controls in the
majority of cellular mRNAs.
INTRODUCTION
Eukaryotic gene expressions are controlled at several
levels. Compared with the knowledge on their
transcriptional regulations, still limited knowledge is
accumulated on their translational regulations. In this
respect, there is an interesting set of genes: several
vertebrate mRNAs which code ribosomal proteins or
translation elongation factors (EF) have a 4–15 oligo-
pyrimidine long tract on their 50-end, and they are called
TOP (terminal oligo-pyrimidine) genes (1–3). This
sequence is thought to serve as a cis-regulatory element
which inhibits the binding of translational regulatory
proteins or the translational machinery itself. As a result,
the translations of these genes are inhibited at the growth
arrest of cells. More speciﬁcally, when a cell is faced with
starvation or treated by some chemicals such as 12-O-
tetradecanoyl-1-phorbol-13-acetate (TPA), mRNAs of
TOP genes, which are normally associated with poly-
somes, change their state into the translationally inactive
‘sub-polysome’ while most non-TOP mRNAs stay in the
‘polysome’ state (1–4).
The TOP motif may also function as a part of a
cis-regulatory element for transcription. For example, in
a typical TOP gene, EF1-A, at least three T’s in the tract
must exist for its high transcription activity (5). In fact,
EF1-A is known as one of the most highly expressed genes
in a cell, and its promoter region has remarkable activity
for transcription (6). In addition, the conservation around
the transcriptional start sites (TSSs) of ribosomal genes
extends to upstream untranscribed regions, such as (Y)2 |
CTY(T)2(Y)3,where ‘|’ denotes TSS. The possibility that
this motif is bound by some transcription factors has been
implicated (7). Therefore, the TOP motif is unique in
cooperatively controlling the gene expressions at both the
transcription and translation levels.
In spite of potential importance and interests in the
balance between the transcriptional and translational
regulations there are only few estimations about the
total number of translationally controlled genes or TOP
genes, in particular, which include all of ribosomal protein
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tionally regulated genes. Although many studies have been
reported on the pathway of TOP-dependent translational
regulation (8–11), they did not aim at comprehensive
identiﬁcation of those genes in the human genome. Indeed,
there have been a few pre-genome era studies, which aimed
at this subject. By ﬁnding a simple pattern CmTnC (where
m=0,1,2 and n>0) against 1496 human full-length
cDNAs, Kato et al. (12) identiﬁed 21 TOP genes besides
ribosomal proteins. Based on this, Amaldi and Pierandrei-
Amaldi (1) estimated that the total number of TOP genes
should be at least 100. However, no update has been made
since then and, to date, genes coding most ribosomal
proteins (2,13), translation EFs (EF1-A, EF1-B and EF-2),
hnRNP A1, laminin receptor 1, nucleophosmin 1, polyA
binding protein 1 and tumor protein translationally con-
trolled 1 have been considered as the only TOP genes (3).
For the genome-wide identiﬁcation and characteriza-
tion of TOP genes, it is essential to know the accurate
position of TSSs because pseudo-TOP motif could occur
frequently by chance on 50-UTRs/upstream sequences.
Thus, the 50-end sequence information of full-length
cDNAs is quite valuable. We have been collecting and
analyzing 50-end clones obtained by the oligo-capping
method (14) as well as the cap trapper method (15). Our
database, DataBase of Transcription Start Sites (DBTSS),
contains a large number of 50-end clones which are used to
identify accurate TSSs in the genomes of various species
(16–18). Using this information, we performed the ﬁrst
post-genome era comprehensive detection of TOP gene
candidates in the human genome as well as their veriﬁ-
cation with a sedimentation experiment.
MATERIALS AND METHODS
Datasetsfor human and mouse TSSs
In DBTSS version 5.1, there are 425117 human TSSs
corresponding to 19573 NCBI reference sequence
(RefSeq) genes. Among them, we ﬁrst used the set of 921
genes (921 TSSs) that have more than 10 clones, of which
more than a half start from the same TSS. This dataset
contained 48 known TOP genes and 873 presumed non-
TOP genes. For the screening of TOP candidates, we used
only TSSs that were indicated by multiple clones to
increase reliability. This reduced the TSS number to
87397 (13717 RefSeq genes) for the human genome.
We also used mouse TSS information from DBTSS.
149876 TSSs, which correspond to 14745 mouse genes,
are registered. Because the number of 50-end clones is
relatively small for mouse, we used all TSSs to detect TOP
gene candidates.
Algorithms
A position speciﬁc weighted matrix (PSWM) of the TOP
motif was constructed based on 48 known TOP genes as
shown in Figure 1C. The score was calculated by the
following formula:
score ¼
X l
i¼1
log
nif þ 1
  
ðNi þ 4Þ
  1=4 ðÞ
  
where l: length of the matrix, which is taken to be 11; nif:
the observed number of base ‘f’ (A, C, G or T) at the i-th
position in the training; Ni: sum of the observed number of
all bases at i-th position, which is equal to 48; the base of
the logarithm was taken to be 10. We deﬁned a gene as
a TOP gene candidate if (i) its score >0.1, (ii) its +1
position is ‘c’ (iii) the positions  1 to +4 are pyrimidines.
Gene expression preference using expression breadth
In order to estimate tissue speciﬁcity of the genes, we used
‘expression breadth’ (19,20). First, we obtained human
gene expression data, based on Aﬀymetrix microarray
data, from the mammalian gene expression atlas (http://
symatlas.gnf.org/SymAtlas/) (21). The data contains
expression data for 79 human tissues. Aﬀymetrix probe
IDs were connected with RefSeq ID using the anno-
tation table in the database. We deﬁned that a gene which
showed on expression level  200 in a given tissue is
expressed, and counted the number of tissues in which it is
expressed.
Gene Ontology (GO) annotation
We obtained the information of GO terms (22) from the
‘gene2go’ and ‘gene2refseq’ tables in NCBI (http://
www.ncbi.nlm.nih.gov/). The ‘GOslim’ information in
European Bioinformatics Institute (EBI, http://www.
ebi.ac.uk/GOA/downloads.html) was used to simplify
the GO annotation by obtaining their top-level GO
terms. Since some GO terms did not correspond to GO
slim terms, we added such GO terms to our extended
GO slim set. The P-value for each GO term was calculated
assuming the hypergeometric distribution and was cor-
rected according to the Bonferroni Correction (http://
mathworld.wolfram.com/BonferroniCorrection.html)
Preparation of polysomal andsub-polysomal fractions
We used exactly the same methods and samples as those
previously reported (23). Namely, HL-60 rapid growth cell
(RG) derived from HL-60 cell lines was cultured. TPA
treated cell lines (TPA+) and untreated cell lines (TPA )
were prepared. Fractionation of HL-60RG polysomes
and isolation of RNA contained in the fractions were
carried out with a modiﬁed published protocol (24).
Approximately 3 10
7 cells were used for each gradient
(growing cells, 4 10
5 cells/ml; TPA+ cells, 50nM TPA,
48h). Before harvesting, cells were incubated with the
medium containing 100mg/ml cycloheximide for 5min and
washed twice with PBS containing 100mg/ml cyclohex-
imide. Cell pellets were resuspended in 1ml of lysis buﬀer
(20mM Tris-HCl (pH 7.5), 10mM NaCl, 3mM MgCl2,
0.04M sucrose, 0.5% Nonidet P40, 1mM dithiothreitol)
containing 100 units of RNase inhibitor and lysed by
incubation on ice for 10min with occasional shaking.
Nuclei and cell debris were removed by centrifugation
at 1000g for 10min at 48C. The lysate was layered on
top of a 11ml 15–50% (w/v) sucrose gradient and
centrifuged at 36000rpm in a Beckman SW41Ti rotor
for 2h 15min at 48C.
Using a density gradient fractionator (Model 152–001
Towa Labo, Misaki-cho, Chiyoda-ku, Tokyo, Japan),
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monitoring absorbance at 260nm. Each fraction was
treated with proteinase K, and RNA was extracted by
phenol/CHCl3, precipitated with ethanol, and analyzed
for each mRNA species. We deﬁned the fractions 1–5 as
the sub-polysomal fraction and 7–11 as the polysomal
fraction, as shown in Figure 3.
Quantitative RT–PCR for detecting enrichment
of theTOPs in thesub/polysome fractions
For negative controls, we sorted genes in DBTSS accord-
ing to the number of 50-ESTs expressed in HL-60RG cells.
The top nine genes which were not TOP candidates were
chosen. We also added the glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) gene as a negative control. PCR
primers were constructed by Primer3 (25).
Twenty microlitres PCR mixture contained 1  Power
SYBR Green PCR mixture (Applied Biosystems, Lincoln
Centre Drive Foster City, CA, USA), 1ng/ml cDNA
sample, and 0.125pM primers. PCR ampliﬁcation con-
sisted of pre-heating (508C for 2min, 958C for 10min),
and 35 cycles of 958C for 30s, 578C for 1min, 728C
for 1min. We used the HT7000 Sequence Detection
System (ABI PRISM) to measure the expression level of
mRNAs. The HT7000 reports the number of the cycle
when the ﬁrst ﬂuorescence is observed. We regarded the
ratio of these values between TPA+ samples and TPA 
samples as the expression diﬀerence between the two
states. All data including experimental results and
predicted TOP gene candidates can be downloaded at
ftp://ftp.hgc.jp/pub/hgc/db/dbtss/Yamashita_et_al.
To estimate the rough number of ribosome on ORF or
mRNAs, ﬁrst we used the refGene.txt table from
University of California Santa Cruz genome browser
(http://genome.ucsc.edu/) to obtain ORF and mRNA
length. Then we estimated 1 ribosome/150bp, as was
previously reported in eukaryotic cells (26).
RESULTS
Initial setof TOP genes
It is now established that most genes have multiple TSSs
(27). For example, tumor protein translationally con-
trolled 1, which is a known TOP gene, has a major TSS at
44813318 on minus-strand of chromosome 13, and more
than 30 TSSs are observed around it (Supplementary
Material Figure 1). Thus, to construct a ﬁrm criterion for
ﬁnding TOP gene candidates, we initially selected 921
genes that have a dominant and stable TSS; more speci-
ﬁcally, (i) genes whose TSS(s) was determined by no less
than 10 clones were chosen and (ii) those where at least a
half of these clones start from the same TSS were further
selected (the list of these genes is shown in the
Supplementary information 1). This gene set included 48
known TOP genes, which code 45 ribosomal proteins,
tumor protein translationally controlled 1, eukaryotic
translation EFs 1 and 2. Since they correspond to 56% of
known or suggested TOP genes, TOP genes may tend to
have dominant TSSs.
With the Sequence logo representation, these 48 genes
are shown to have a clear TOP motif while the other genes
seem to be characterized with the initiator sequence (28)
(Figure 1B). The consensus motif sequence is almost the
same with the previously-reported (Y)2 | CTY(T)2(Y)3,
which was obtained from the ribosomal protein genes only
(7). To detect all potential TOP genes in our dataset, we
constructed a PSWM based on the conserved  4t o+ 7
region of these 48 genes (Figure 1C and D). With this
PSWM, the minimum score of known TOP genes was 0.12
(NM_021029: ribosomal protein L36, Supplementary
Material Figure 2); thus, (i) we set our threshold value
to 0.1. In addition, (ii) all TOP genes have C at +1
position and (iii) the bases from  1 to +4 were all
pyrimidines. Therefore, we combined these three criteria
to detect candidates. In the remaining 873 genes in our
initial gene set, we further detected with these criteria 18
novel TOP gene candidates, which include eukaryotic
translation initiation factors 2, 3 and 4A.
Detectionof TOP gene candidates from all TSSs
The distribution of the scores of randomly sampled
genome sequences (for a million times) showed the
average  0.87 and the SD 0.53, which means that genes
whose score exceed 0.1 are TOP gene candidates
(P<0.05). We then calculated the score for all 87397
TSSs corresponding to 13717 human genes (Note that
they include all of the above 921 TSSs). Of these, 1645
genes (2772 TSSs) fulﬁlled the criteria (Supplementary
Material table 2). They contained not only all known TOP
genes but also 75 genes coding ribosomal proteins and 22
translation-related genes (such as the translation initiation
factors or EFs) (Table 1, panel A, B).
We then detected 816 TOP gene candidates (967 TSSs)
from 149876 mouse TSSs (14745 genes) under the same
conditions. In the 1645 human TOP gene candidates, 1314
of them had homologous counterparts in the 14745 mouse
genes. But only 239 of them were also identiﬁed as TOP
candidates in mouse. This subset contained 54 of the 58
known-TOP genes with mouse homologs. This consensus
gene set also included 49 genes coding ribosomal proteins
and 9 translation-related genes.
GO annotation and expression profiles
ofTOP gene candidates
We obtained two kinds of datasets for TOP gene can-
didates: the 1645 genes relying on only human informa-
tion and the 239 genes relying on both human and mouse
information. To characterize these TOP genes candidates,
we used GO annotations. As shown in Table 2, panel A,
10 GO terms such as ‘protein biosynthesis’, ‘ribosome’
and ‘regulation of translation initiation’ were signiﬁcantly
frequent. Though the frequency of ‘translation elongation’
was not regarded as signiﬁcant with our threshold, it was
in the 11th position. The same analysis was performed
using the GO slim terms for the detection of a more global
and unbiased tendency (Table 2, panel B). Among those,
terms such as ‘receptor activity’, ‘channel or pore class
transporter activity’ and ‘cell communication’ were less
frequent while ‘lysosome’, ‘cytoplasm’, ‘intracellular
Nucleic Acids Research, 2008, Vol. 36, No. 11 3709activity’, ‘structure molecular activity’ or ‘translation
regulator activity’ were more frequent.
To characterize the TOP candidates, we used ‘expres-
sion breadth’ to compare the expression preference
between TOP and not-TOP genes. As shown in
Figure 2, TOP candidates tend to be expressed in more
tissues, in other words, in a more house-keeping manner
while the other genes tend to be more tissue-speciﬁc. These
tendencies were observed in both the 1645 group and
the 239 group (data not shown) and were highly signiﬁcant
by Wilcoxon’s rank-sum test (both of them showed
P<1e 200). We also counted the number of cDNA
libraries where the 50-end clones of each gene in DBTSS
were obtained, and obtained the same tendency
(Supplementary material Figure 3).
Experimental validation fortranslational regulation
We experimentally validated whether translational con-
trols were observed upon TPA treatment for some of our
predicted TOP gene candidates. The translational controls
were evaluated by sedimentation experiments. For this,
mRNAs were extracted for every fraction of either sub-
polysomes or polysomes (Figure 3A) before and after the
TPA treatment in human HL-60RG cells (23) and the
relative abundance of them was detected by semi-
quantitative real-time PCR. Before the sedimentation
experiment, the RNA levels (transcription level) of all
239 genes with and without TPA treatment (TPA+/TPA-)
were measured by real-time PCR. In the following
experiments, we used 86 genes whose transcription level
did not vary signiﬁcantly on the TPA treatment.
Figure 3B depicts the results of the sedimentation
experiments for two new TOP gene candidates (EEF1G
and SDBCAG84), one known TOP gene (RPL19) and one
negative control (GAPDH) (For further details on frac-
tion distributions, see Supplementary Material Figure 4).
Distributions of the mRNAs of RPL19, EEF1G and
SDBCAG84 shifted to the sub-polysomal fractions after
TPA treatment. In contrast, signiﬁcant population of the
mRNAs of GAPDH remained at the polysomal fractions.
These results are consistent with the general notion of
TOP genes. In the cases of the mRNAs of EEF1G and
SDBCAG84, which are newly identiﬁed TOP candidates,
the degree of translational controls estimated by the ratio
between the sub-polysomal and polysomal fractions
(Sub/Pol) were more than 1000-fold higher than the
positive controls.
In total, we examined translational controls for
91 genes, which consist of 47 newly predicted genes,
34 known TOP genes and 10 negative controls. It contains
RPL19, RPL13a and RPS27 genes which are well experi-
mentally established as TOP genes (4). The mRNAs of
most of the genes examined were enriched in the poly-
somal fraction. After TPA treatment, mRNAs of 63 genes
(78%) showed some shift towards the sub-polysomal
Figure 1. Sequence logo of the most ﬁxed TSSs and known TOP genes. (A) We constructed the Sequence logo of the most ﬁxed 931 TSSs
corresponding to 931 genes. 873 other genes (B) and 48 TOP genes group (C) and (D) PSWM of TOP genes. The black box at +1 position in
the table shows all of the TOP genes showing same nucleotide namely ‘C’. The gray boxes in the table from  1:+4 shows the pyrimidine region.
These two conditions were considered to detect TOP gene candidates.
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fraction became the major fraction (Figure 3C). Among
them, 31 of 34 known TOP genes were included. On the
other hand, mRNAs of all of the negative control genes
still remained in the polysomal fraction (Figure 3D).
Interestingly, some of the new TOP candidates showed no
signiﬁcant increase in the ratio of Sub/Pol in the fractions
corresponding to the ORF regions. For example, in the
case of the TMEM18 mRNA, which has relatively long
30-UTR (1645 bases out of 2122), the ratio was 1.2 (the
most bottom line of Figure 3B). However, in this case,
when the ratio of Sub/Pol corresponding to the entire
mRNA was assessed, it increased to 1374. This observation
may suggest that in some mRNAs, ribosomes are also
associated outside of the ORF and play roles in controlling
the translational eﬃciency.
Table 1. Relationship between TOP gene candidates and translation-related genes
RefSeq ID Gene name Deﬁnition
Panel A
NM_001402 EEF1A1 Eukaryotic translation elongation factor 1-a
NM_001958 EEF1A2 Eukaryotic translation elongation factor 1-a
NM_001959 EEF1B2 Eukaryotic translation elongation factor 1-b
NM_001960 EEF1D Eukaryotic translation elongation factor 1-d
NM_001404 EEF1G Eukaryotic translation elongation factor 1
NM_001961 EEF2 Eukaryotic translation elongation factor 2
NM_003907 EIF2B5 Eukaryotic translation initiation factor 2B,
NM_003908 EIF2S2 Eukaryotic translation initiation factor 2-b
NM_001415 EIF2S3 Eukaryotic translation initiation factor 2,
NM_013234 eIF3k Eukaryotic translation initiation factor 3
NM_003758 EIF3S1 Eukaryotic translation initiation factor 3,
NM_003750 EIF3S10 Eukaryotic translation initiation factor 3,
NM_003757 EIF3S2 Eukaryotic translation initiation factor 3,
NM_003756 EIF3S3 Eukaryotic translation initiation factor 3,
NM_003755 EIF3S4 Eukaryotic translation initiation factor 3,
NM_003754 EIF3S5 Eukaryotic translation initiation factor 3,
NM_016091 EIF3S6IP Eukaryotic translation initiation factor 3
NM_003753 EIF3S7 Eukaryotic translation initiation factor 3
NM_001967 EIF4A2 Eukaryotic translation initiation factor 4A,
NM_001417 EIF4B Eukaryotic translation initiation factor 4B
NM_001418 EIF4G2 Eukaryotic translation initiation factor 4
NM_022170 WBSCR1 Eukaryotic translation initiation factor 4H
Panel B
NM_004280 EEF1E1 Eukaryotic translation elongation factor 1
NM_001412 EIF1AX X-linked eukaryotic translation initiation
NM_004681 EIF1AY Eukaryotic translation initiation factor 1A, Y
NM_004836 EIF2AK3 Eukaryotic translation initiation factor 2-a
NM_001414 EIF2B1 Eukaryotic translation initiation factor 2B,
NM_014239 EIF2B2 Eukaryotic translation initiation factor 2B,
NM_020365 EIF2B3 Eukaryotic translation initiation factor 2B,
NM_015636 EIF2B4 Eukaryotic translation initiation factor 2B,
NM_012199 EIF2C1 Eukaryotic translation initiation factor 2C, 1
NM_012154 EIF2C2 Eukaryotic translation initiation factor 2C, 2
NM_024852 EIF2C3 Eukaryotic translation initiation factor 2C, 3
NM_017629 EIF2C4 Eukaryotic translation initiation factor 2C, 4
NM_004094 EIF2S1 Eukaryotic translation initiation factor 2,
NM_003752 EIF3S8 Eukaryotic translation initiation factor 3,
NM_003751 EIF3S9 Eukaryotic translation initiation factor 3,
NM_001416 EIF4A1 Eukaryotic translation initiation factor 4A,
NM_001968 EIF4E Eukaryotic translation initiation factor 4E
NM_004095 EIF4EBP1 Eukaryotic translation initiation factor 4E
NM_004096 EIF4EBP2 Eukaryotic translation initiation factor 4E
NM_003732 EIF4EBP3 Eukaryotic translation initiation factor 4E
NM_004846 EIF4EL3 Eukaryotic translation initiation factor 4E-like
NM_019843 EIF4ENIF1 Eukaryotic translation initiation factor 4E
NM_004953 EIF4G1 Eukaryotic translation initiation factor 4
NM_003760 EIF4G3 Eukaryotic translation initiation factor 4
NM_001969 EIF5 Eukaryotic translation initiation factor 5
NM_001970 EIF5A Eukaryotic translation initiation factor 5A
NM_015904 EIF5B Translation initiation factor IF2
NM_005801 SUI1 Putative translation initiation factor
NM_005726 TSFM Ts translation elongation factor, mitochondrial
NM_003321 TUFM Tu translation elongation factor, mitochondrial
The columns show, respectively, RefSeq ID: NCBI reference sequence ID, gene name: gene name in short form, deﬁnition:
deﬁnition of the gene. Panel A detected TOP gene candidates. Panel B genes not detected as TOP gene candidates.
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oftranslation status
We examined the correlation between the TOP activity
and the lengths of 30-UTR, 50-UTR, ORF and RNA.
Ledda et al. (29) previously reported that the 30-UTR
length of mRNAs coding TOP genes aﬀects their
translational eﬃciency. We also observed a signiﬁcant
correlation between the length of 30-UTR and the ratio
between the two fractions in our data of 84 TOP gene
candidates (r= 0.56) (Figure 4A). Moreover, we
observed similar correlation between the translational
eﬃciency and total mRNA length (r= 0.61), the ORF
length (r= 0.53) and the 50-UTR length (r= 0.42)
(Figure 4B–D). The fact that the correlation coeﬃcient
with mRNA length was the greatest may indicate that
entire mRNA parts are involved in translational control as
well as the UTR and ORF parts in many cases.
DISCUSSION
This is the ﬁrst article which describes the identiﬁcation of
the translational regulatory motifs by utilizing TSS infor-
mation. Based on exact positional information of the
TSSs, we could identify and characterize TOP genes in a
highly accurate and comprehensive manner. Previously,
use of the TSS information has been mainly focused on
the analysis of transcriptional regulatory elements in
promoters. We showed that TSS information is also
advantageous to identify cis-regulatory elements in
mRNAs, which also play roles in determining the expres-
sion levels of ﬁnal protein products.
So far, there were only eight genes reported to be
human TOP genes besides ribosomal protein genes (3).
Table 2. GO analysis of TOP genes
GO ID Category Deﬁnition All 1645 genes 239 genes
No. of genes P-value No. of genes P-value
Panel A
GO:0016499 Process Protein biosynthesis 249 127 7.1E 52 60 4.0E 52
  
GO:0016505 Function Structural constituent of ribosome 144 86 1.4E 42 52 2.2E 55
  
GO:0016511 Component Ribosome 116 73 1.6E 38 42 1.1E 44
  
GO:0016519 Component Cytosolic large ribosomal subunit (sensu Eukaryota) 25 22 9.0E 18 16 8.7E 23
  
GO:0016520 Component Cytosolic small ribosomal subunit (sensu Eukaryota) 12 12 9.3E 12 9 2.9E 14
  
GO:0016559 Function RNA binding 382 91 7.8E 11 33 2.8E 14
  
GO:0016584 Process Regulation of translational initiation 23 14 3.8E 08 2 6.1E 02
 
GO:0016600 Function Translation initiation factor activity 54 21 4.6E 07 4 1.5E 02
 
GO:0016601 Function rRNA binding 11 8 5.3E 06 6 1.2E 08
  
GO:0016624 Component Lysosome 97 28 6.8E 06 3 2.4E 01
 
GO:0016742 Process Translational elongation 15 9 1.4E 05 4 1.10E 04
Panel B
GO:0004872 Function Receptor activity 1065 88 2.0E 05 12 6.0E 02
 
GO:0015267 Function Channel or pore class transporter activity 312 16 2.0E 05 2 8.5E 02
 
GO:0007154 Process Cell communication 2412 242 3.0E 04 37 2.1E 01
 
GO:0005737 Component Cytoplasm 2923 520 6.8E 25 128 1.2E 27
  
GO:0009058 Process Biosynthesis 972 226 3.6E 24 78 1.2E 31
  
GO:0005198 Function Structural molecule activity 542 135 3.3E 17 61 1.9E 32
  
GO:0005622 Component Intracellular 6139 879 2.7E 13 160 1.1E 11
  
GO:0043170 Process Macromolecule metabolism 3342 507 3.9E 10 107 7.8E 12
  
GO:0045182 Function Translation regulator activity 98 29 2.7E 06 8 3.4E 04
  
GO:0008152 Process Metabolism 5838 782 2.7E 05 144 6.6E 08
  
The columns show, respectively, GO ID: GO ID, category: one of the category of the GO ID, deﬁnition: deﬁnition of GO ID, all: observed number
of terms in whole of the gene set, 1645 genes P-value: the P-value of 1645 gene set according to hypergeometrical test, 239 genes p-value: the P-value
of the 239 gene set according to hypergeometrical test. All of the GO terms which are overrepresented (normal) or underrepresented (italic) under the
threshold (P<0.05 with Bonferroni correction) are shown.
  and
   indicate statistical signiﬁcance in either of the two sets and in both sets,
respectively. Panel A all of the 4753 GO observed in the dataset. After Bonferroni correction, we set the threshold to 1.1e 5. Panel B The results of
33 GO slims. After Bonferroni correction, we set the threshold to 1.5e 3.
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Figure 2. Tissue speciﬁcity of TOP genes candidates with a box-and-
whisker plot. The horizontal axis shows 1645 TOP genes candidates
(TOP) and 6174 not TOP candidates (not-TOP). The vertical axis shows
‘expression breadth’. This ﬁgure is drawn with ‘boxplot’ in R package.
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to be elucidated. We performed a systematic survey using
the accurate TSS information. We detected as much as
1645 candidates, which included 83 (97%) of 86 known
TOP genes. The three missing genes were overlooked
because their clones were mapped to multiple loci and
were not stored in DBTSS. Therefore, we believe that
there are not many false negatives in our candidate set.
In the 1645 gene set, several plausible genes were
included. For example, there were many translation
initiation factors, such as initiation factors 2, 2b, 2B, 3,
4, 4A, 4B and 4H (Table 1, panel A). On the other hand,
initiation factors 2C, 4E and 5 were not detected as TOP
genes (Table 1, panel B). There are 11 paralogous genes
coding initiation factor 3 in RefSeq and 9 of them were
detected as TOP gene candidates. Although initiation
factors have not been reported as TOP genes, it is very
likely because all known TOP genes are related to the
translational activity.
In a previous study, Levy et al. (30) reported that a
purine, mostly a G, was frequently found at the end of
pyrimidine stretch. In fact, they reported 8 out of 12 TOP
genes had ‘G’ at the end of pyrimidine stretch. To check
this idea, we picked up the ﬁrst base after the pyrimidine
stretch of each TOP candidates. From 1645 genes, we
obtained 2772 TSSs which showed TOP positive. We
observed 891 ‘A’ terminal and 1881 ‘G’ terminal among
them, so that similarly to the previous research, we also
found frequent ‘G’: the ratio was A:G=1:2.11.
Amaldi and Pierandrei-Amaldi (1) estimated that the
number of TOP genes are no less than 100. Davuluri et al.
(31) predicted 152 (6.6%) TOP genes from a 2312 full-
length gene set. Our results suggest that there are much
more TOP genes beyond the category of so-called
‘translation-related’ genes. For example, we identiﬁed
transmembrane protein 30 as a TOP candidate. This gene
is a homolog of yeast CDC50 genes, which is necessary for
subcellular localization of yeast Bni1p and plays a pivotal
role in asymmetrical cell division (32). Although their gene
functions in humans remain elusive, it is possible that the
wider variety of genes involved in various cellular
functions, such as transmembrane proteins and signal
transducing proteins, are also subjected to translational
regulations unlike previously thought. Of course, there
still remains some possibilities that our set contains a
signiﬁcant number of false positives. Indeed, there were
only 239 genes that are predicted to be TOP genes in both
human and mouse. However, it is as well possible that
translational regulations might be even more evolutionary
diverged than transcriptional regulations, for which
signiﬁcant species-speciﬁc traits have been identiﬁed (33).
If our estimation of the frequency of the TOP genes is
totally reliable, the translational control of the mRNAs
should take place very abundantly within human cells. We
showed that the mRNA expression levels of the TOP
genes are generally higher and ubiquitously expressed
(Figure 2). It has been estimated that  15% of total
cellular mRNAs is occupied with ribosomal protein
mRNAs (34); therefore, >20% of total mRNA could be
translationally regulated (35). Based on our prediction, the
percentage is even higher: 41.9% of total 1034085 50-end
Figure 3. Expression proﬁles for TOP genes candidates. (A) HPLC
fraction of cell elutions. The fractions were divided into Sub: sub-
polysomal groups (1–5) and Poly: polysomal groups (7–11). Left:
fraction of cells not treated with TPA, Right: fraction of cells treated
with TPA. (B) Several examples of expression of detected TOP genes
candidates. Relative expression levels, the highest one corresponding to
1, are shown. RPL19: ribosomal protein L19 for positive control,
GAPDH for negative control, SDBCAG84: serologically deﬁned breast
cancer antigen 84, EEF1G: eukaryotic translation EF1-G, TMEM30A:
transmembrane protein 30A. We showed the fraction corresponding
to the potential ribosome number on ORF assuming one ribosome/
150bp. The number in each ﬁgure indicates the ratio of
(TPA+:Sub/TPA+:Pol)/(TPA :Sub/TPA :Pol). For further details
on fraction distributions, see Supplementary Research Data Figure 3.
(C) Expression ratios of 81 candidates. (D) Expression ratios of 10
negative controls. Black bars correspond to the expression ratio with
TPA treatment, and gray bars correspond to the expression ratio
without TPA treatment. The y-axis shows the ratio of mRNA
expression in polysome and sub-polysome fractions. These ratios were
converted as log ratio.
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To our surprise, the extent of the translational induc-
tion diﬀered between genes. It seems that some of the 239
candidates showed relatively small change of translational
status upon TPA treatment (Figure 3B). It seems that the
TPA eﬀect on TOP mRNAs is dependent on several
factors. Ledda et al. (29) reported that the 30-UTR length
aﬀects the translational regulation of TOP genes. We
could conﬁrm this with our own data but the correlation
was even stronger with the mRNA length (Figure 4).
Considering the fact that the correlation between the
mRNA length and the degree of the ‘TOP-ness’ is the
most strict (left upper corner in Figure 4C), the TOP
eﬀects seem to be the most straightforward for the
mRNAs that are less than 1000 bases long with relatively
short UTRs. Actually, this population contains 64 (56%)
known TOP genes. Furthermore, we also observed that in
some mRNAs the TOP-mediated depletion of the poly-
somes are not clear in the ORF regions but evident when
the entire mRNA regions, including UTRs, were assessed.
When a trans-factor binds to the 50-end of TOP mRNAs
under particular cellular conditions, it invokes the
dissociation of bound ribosomes; in TOP genes of longer
mRNAs or 30-UTR, however, ribosomes might remain
associated outside of the ORF regions, which are hard to
be dissociated, thus, showing some buﬀering eﬀects on the
TOP activity.
In this study, we performed a genome-wide detection of
human TOP genes. Our results strongly support the idea
that the TOP genes are not restricted to genes of limited
functional category, but control the expression of a wider
variety of genes and a major population of cellular
mRNAs. Further analyses on the additional factors to
modulate the TOP activity of the newly identiﬁed can-
didates should also reveal underlying molecular mecha-
nisms which realizes the translational control at the
versatile levels. Our study should lay foundation for an
in-depth understanding of the genome-wide ﬁgure of
translational controls of gene expressions, for which
relatively little knowledge has been accumulated.
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